Resistance to type II JAK2 inhibition in MPN is dependent on targetable MAPK activation and is reversible Meeting Abstract
| Authors: | Szybinski, J.; Codilupi, T.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Radimerski, T.; Levine, R. L.; Meyer, S. C. |
| Abstract Title: | Resistance to type II JAK2 inhibition in MPN is dependent on targetable MAPK activation and is reversible |
| Meeting Title: | 2nd Swiss Hematology & Oncology Congress (SOHC) |
| Journal Title: | Swiss Medical Weekly |
| Volume: | 149 |
| Issue: | Suppl. 237 |
| Meeting Dates: | 2019 Jun 26-28 |
| Meeting Location: | Zurich, Switzerland |
| ISSN: | 1424-7860 |
| Publisher: | E M H Swiss Medical Publishers Ltd |
| Date Published: | 2019-06-21 |
| Start Page: | 23S |
| Language: | English |
| ACCESSION: | WOS:000473833600059 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1080 -- Source: Wos |
MSK Authors
-
775Levine